SNYR: Synergy CHC Corp. Stock

by  •  • Comments Off on SNYR: Synergy CHC Corp. Stock

SIC 2833 – Medicinal Chemicals and Botanical Products

Valuation
Market Cap ($M) 21.43
Enterprise Value ($M) 48.26
Book Value ($M) -16.63
Book Value / Share -1.94
Price / Book -1.29
NCAV ($M) -16.91
NCAV / Share -1.97
Price / NCAV -1.27

Profitability (mra)
Return on Invested Capital (ROIC) 0.20
Return on Assets (ROA) n/a
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 0.83
Current Ratio 0.93

Balance Sheet (mrq) ($M)
Current Assets 16.06
Assets 16.34
Liabilities 32.97
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 34.83
Operating Income 5.80
Net Income 2.12
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -4.80
Cash from Investing 0.00
Cash from Financing 4.80

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
03-20 13G Knight Therapeutics Inc 17.03
10-31 13D Ross Jack 54.10 -91.75
10-25 13G Sanders Morris Harris Llc 5.24

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-31 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 ☐ TRANSITION REPORT PURSUA
2024-12-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 ☐ TRANSITION REPO

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 60,540 282,674 21.42
2025-04-16 178,833 786,600 22.73
2025-04-15 7,420,740 23,091,577 32.14
2025-04-14 9,400 36,832 25.52

(click for more detail)

Similar Companies
SNPX – Synaptogenix, Inc. SNSE – Sensei Biotherapeutics, Inc.
SNTI – Senti Biosciences, Inc. SONN – Sonnet BioTherapeutics Holdings, Inc.
SPRB – Spruce Biosciences, Inc.


Financial data and stock pages provided by
Fintel.io